# Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane

> **NCT00059852** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 61 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** erlotinib hydrochloride
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00059852
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-08
- **Final completion:** 2009-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059852, "Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00059852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*